Yoed Rabin joined the Department of Mechanical Engineering at Carnegie Mellon University in 2000. Previously, Rabin held academic positions at the Division of Surgical Oncology and the Department of Human Oncology at Allegheny University of the Health Sciences—affiliated with Hahnemann University Hospital (1994-1998), and at the Department of Mechanical Engineering at the Technion—Israel Institute of Technology (1997-2000).
Rabin has a broad range of research interests in areas of energy modalities in biology and medicine, including cryopreservation (preservation of tissues at very low temperatures), cryosurgery (the controlled destruction of undesired tissues, such as cancerous tumors, by freezing), hyperthermia (the destruction of tissue at elevated temperatures), and heat and mass transfer in biological systems.
Research activity at the Biothermal Technology Laboratory, which Rabin heads, integrates the development of sensors, instrumentation, surgical devices, measurement techniques, physical modeling, numerical techniques, computation tools, and thermal design. Key research projects at the Biothermal Technology Laboratory include computerized training tools for cryosurgery, wireless implantable temperature sensors, computerized planning of cryosurgery, thermo-mechanical stress in cryopreservation, thermal expansion of cryoprotective agents combined with synthetic ice blockers, and developing a device for visualization of large-scale cryopreservation.
1994 D.Sc., Mechanical Engineering, Technion, The Israel Institute of Technology
1991 MS, Ben-Gurion University
1989 BS, Ben-Gurion University
National Institutes of Health
Rabin recognized for cryopreservation work
MechE’s Yoed Rabin has been recognized multiple times for his work with cryopreservation. Rabin received two grants from the National Institutes of Health.
Introduced to cryopreservation of organs and tissues as a master's student, Purva Joshi decided to pursue a Ph.D. to continue this research in the Biothermal Technology Laboratory.
Rabin elected to Board of Governors of International Society of Cryosurgery
MechE's Yoed Rabin has been elected to the 20th Board of Governors of the International Society of Cryosurgery (ISC).
Rabin receives funding from NIH for nanowarming research
Recently, the National Heart, Lung, and Blood Institute awarded the Biothermal Technology Lab at CMU, headed by MechE’s Yoed Rabin, a research grant for nearly $500,000.
Cryopreservation a possible solution for storing and preserving donor organs
MechE’s Yoed Rabin and Michael Taylor were among 42 scholars who co-authored a report calling for the reemergence of organ-preservation technology.
Transforming medicine through organ and tissue preservation
Rabin and collaborators discuss the promise of organ and tissue preservation to transform medicine.
Rabin highlights importance of engineering in cryopreservation
MechE’s Yoed Rabin sees engineering as integral to the necessary improvements needed in the cryopreservation of human tissue.
Organ banking: mechanical engineers have the know-how
Carnegie Mellon University's Yoed Rabin is the lead author of a feature article in the May 2017 issue of Mechanical Engineering Magazine, a publication of the American Society of Mechanical Engineers (ASME).
Rabin gives keynote at Computational and Mathematical Biomedical Engineering conference
MechE’s Yoed Rabin will deliver a keynote lecture at the 5th International Conference on Computational and Mathematical Biomedical Engineering.
Rabin's cryopreservation research featured in Digital Trends
A paper published by MechE’s Yoed Rabin and collaborators from University of Minnesota, Clemson University, and biotech company Tissue Testing Technologies was recently featured in Digital Trends. The team has developed a new “nano-warming” technique that allows frozen organs to be quickly reheated in a way that doesn't damage them.
Rabin featured in ABC News
MechE’s Yoed Rabin was featured in an ABC News article about nanotechnology and cancer detection.
Dowd Seed Fund for Fellowships
Some of the greatest innovations of our time started out with the riskiest ideas. But risky ideas often go unfunded—until someone is brave enough to trust in the researcher's dreams.